Article

Antibiotic Misuse in Pediatric Populations: Causes, Consequences, and Strategies for Mitigation

Susmita Mandal1★, Deep Shende1★ Corresponding author

  1. 1Department of Pharmaceutical Chemistry, Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Sawangi (M), Wardha, Maharashtra, INDIA.

CORRESPONDENCE

Susmita Mandal

Department of Pharmaceutical Chemistry, Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Sawangi, Wardha, Maharashtra, INDIA.

susmita23mandal@gmail.com

Received: 23-02-2026; Revised: 16-04-2026; Accepted: 04-06-2026.

Volume 16, Issue 3 · pp. 984–989 · PUBLISHED Apr-Jun 2026 · DOI: 10.5530/ijpi.20260045

View on IJPI original site ↗

ABSTRACT

Background The increasing risk of antibiotic resistance is a major worldwide health concern, with especially dire repercussions for children. The purpose of this study is to investigate the causes, effects, and preventative measures of paediatric antibiotic abuse. Materials and Methods A thorough investigation of the body of peer-reviewed literature, guidelines, and public health bulletins served as the foundation for this narrative review. In order to determine the main causes of antibiotic overuse and resistance in paediatric care, the study combines information from observational studies, clinical trials, and international health monitoring systems. Results The findings show that improper prescribing methods, parental pressure, ignorance, unclear diagnosis, and systemic healthcare problems are the main causes of antibiotic abuse in children. Antimicrobial Resistance (AMR) has significantly grown, adverse medication reactions have increased, and the gut microbiota has been disrupted. Evidence-based prescribing recommendations, public education campaigns, and antibiotic stewardship programs are among the interventions that have demonstrated encouraging results in lowering abuse. Conclusion The worldwide burden of antimicrobial resistance is still significantly influenced by the overuse of antibiotics in paediatric populations. Public health systems, legislators, carers, and healthcare professionals must all work together in a multidisciplinary manner to address this problem. To protect future generations' health, it is crucial to encourage ethical antibiotic use through stewardship, legislation, and education.

KEYWORDS

0% READ

FULL TEXT

INTRODUCTION

The discovery of antibiotics revolutionized medicine, transforming the cure of bacterial infections and saving countless lives. Yet the general and frequently misguided use of these disease-preventing medications has brought us to a crisis point: the development and quick proliferation of antibiotic resistance. Bacteria, via natural selection, are developing means of resisting the action of antibiotics, making formerly curable infections harder, and sometimes impossible, to treat. The World Health Organization (WHO) has identified antibiotic resistance as one of the most pressing global health concerns, threatening decades of medical advancement and potentially creating a post-antibiotic era (World Health Organization (WHO), 2015). The problem of antibiotic overuse is especially problematic in pediatric groups. Children, with their immature immune systems and distinctive metabolic pathways, are generally more susceptible to the side effects of antibiotics (Centers for Disease Control and Prevention (CDC), 2019). In addition, repeated childhood antibiotic exposure has long-term health impacts, such as altering the gut microbiome and predisposing individuals to allergies and autoimmune diseases (Laxminarayan et al., 2013). At the same time, antibiotics are still inappropriately used among children on a regular basis by virtue of diagnostic ambiguity (Chandy et al., 2013), parental demands (Fleming-Dutra et al., 2016), and systemic obstacles to ideal treatment (Kotwani et al., 2020; Charani et al., 2017).

This article is intended to give an overall review of antibiotic abuse in children. It will discuss the multiple determinants of this issue discuss the long-term implications of antibiotic resistance in children and above all, present evidence-based approaches to limiting misuse and sustaining the efficacy of these vital drugs.

MATERIALS AND METHODS

Determinants of Pediatric Antibiotic Misuse

Misuse of antibiotics in the pediatric population is a multifaceted problem propelled by an intersection of interrelated determinants that cross patient behavior, healthcare practice, and wider systemic determinants. Identifying these drivers is crucial to creating effective and targeted interventions (Costelloe et al., 2010). The key contributing factors leading to pediatric antibiotic misuse are illustrated in Figure 1.

Figure 1: Contributing Factors towards Antibiotic Misuse in Pediatric Populations.

Parental Factors Misconceptions

The main underlying factor being the widespread belief of parents that antibiotics work for viral conditions like the common cold and influenza. This is usually more common in urban areas, where parents are inclined to demand quick relief from the illness of their children and use antibiotics as a quick solution (Barker et al., 2017).

To negotiate a quick fix

Parents in busy urban contexts might pressure health care professionals to prescribe antibiotics regardless of the clinical scenario due to the need for prompt symptom alleviation and perceived necessity for a faster recovery of their child. This pressure may be hard for clinicians to resist, especially in high-volume practice settings (Gelband et al., 2015).

Lack of Awareness

Parents are short of adequate knowledge about antibiotic resistance, its reasons, and its possible long-term implications on their children and the community at large. This ignorance can contribute to a decreased perceived risk that is linked with antibiotic excess (Pharmacy Council of India (PCI), 2016).

Self-Medication

One worrying practice is the use by parents of leftover antibiotics prescribed earlier or acquiring antibiotics without prescription from chemists or other outlets for their children's acute illness. This self-medication circumvents appropriate diagnosis and accounts for a major part of antibiotic abuse (Boeckel et al., 2014).

Healthcare Practices Diagnostic Uncertainty

In the majority of clinical situations, especially in resource-poor communities with restricted access to diagnostic facilities, clinicians tend to use empirical antibiotic prescribing on the basis of clinical suspicion instead of certain microbiological proof of a bacterial infection. This doubt raises the prospect of antibiotic prescription for viral or non-infectious illnesses (Dyar et al., 2017).

Patient Demand Influence

Physicians under pressure from demanding parents might feel obligated to prescribe antibiotics even when not clinically necessary to ensure patient satisfaction and avoid perceived confrontation (McNulty et al., 2013).

Prescribing Habits

Some physicians may have habituated prescribing behaviors, preferring broad-spectrum antibiotics even in cases of infections that can be effectively managed by narrower-spectrum agents. This leads to unwarranted exposure to more-spectrum antibiotics and a faster build-up of resistance (Auta et al., 2019).

Lack of Time and Resources

In hectic clinics and hospitals, health professionals can be short of time for in-depth patient education on the proper use of antibiotics and the dangers of resistance. Limited availability of updated guidelines and antimicrobial stewardship information can also prevent best prescribing practices (Sulis et al., 2020).

Systemic Problems Regulatory Loopholes

In most areas, antibiotics can be freely purchased over the counter without a doctor's prescription, making it easy to self-medicate and misuse. Poor enforcement of prescription-only rules contributes to this issue (Huttner et al., 2013).

Lack of Awareness Campaigns

There is a lack of adequate public health campaigns that provide parents and the wider public with information on antibiotic resistance and correct antibiotic use, which allows misconceptions and incorrect practices to persist.

Financial Incentives

In certain healthcare systems, financial incentives or disincentives may inadvertently affect prescribing practices, and that can result in overuse or underuse of antibiotics.

Access to Healthcare

Unequal access to healthcare can also be a contributory factor. Where there is restricted access to trained healthcare providers, people can self-treat with easily accessed antibiotics, whether or not appropriate.

Impacts of Pediatric Antibiotic Resistance

The misuse of antibiotics in children has significant and extended impacts, both for the individual patient and for public health in a general sense. The most serious consequence is the emergence and dissemination of antibiotic resistance. Table 1 presents the most common misconceptions among parents regarding antibiotic use.

Table 1: Frequent Misconceptions Regarding Antibiotics among Parents.
MisconceptionPercentage of Parents Reporting Belief
Antibiotics work for colds and flu65%
Antibiotics make children better sooner from any sickness.50%
It is fine to discontinue antibiotics when they feel better.40%
Unused antibiotics can be saved for future illnesses30%

Antibiotic Resistance

Antibiotic resistance happens when bacteria become or acquire the capability to live despite exposure to antibiotics that once were effective in killing or suppressing their growth. This may occur as a result of genetic mutations or acquisition of resistance genes from other bacteria. The excessive and inappropriate use of antibiotics create the selective pressure that necessitates this evolutionary process, with the result that the resistant bacteria are more likely to survive and multiply. The impact of antibiotic resistance is serious (Friedman et al., 2016; Gandra et al., 2017; Gould and Bal, 2013).

Failure of Treatment

Infections due to resistant bacteria become harder and even impossible to treat with existing antibiotics. This may result in prolonged sickness, more morbidity, and enhanced mortality rates. Common childhood infections that were previously easily treatable can become deadly.

Increased Healthcare Costs

The treatment of infections caused by resistant bacteria may involve the use of more costly, second-line or last-resort antibiotics, longer hospitalization, and more complicated and intensive medical care, resulting in a tremendous increase in healthcare expenditures. Spread of Resistance: Resistant bacteria are readily transmissible within families, schools, communities, and healthcare facilities, further increasing the issue and complicating the management of outbreaks of infection (Llor and Bjerrum, 2014; Vaz et al., 2015).

Limited Treatment Options

Ongoing emergence and dissemination of resistance risks exhausting the pipeline of useful antibiotics, potentially driving a "post-antibiotic era" in which even trivial infections could again become incurable, sending decades of medical progress into reverse.

Impact on Vulnerable Populations

Children, especially newborns and infants, and those with underlying illness, are often more susceptible to the dangerous sequelae of antibiotic-resistant infections (Wagner et al., 2018; Holloway et al., 2013).

Long-Term Health Impacts

Beyond the short-term risk of resistant infections, antibiotic misuse in the early years of life may have additional long-term health implications (Yadav et al., 2019; Davey et al., 2017).

Gut Microbiome Disruption

Antibiotics, particularly broad-spectrum agents, have the potential to disrupt the precarious balance of the gut microbiome, the complex community of microbes that inhabit the intestines and are responsible for digestion, immunity, and overall health. Early antibiotic exposure in childhood has been associated with long-term changes in the gut microbiome, which may promote conditions such as allergies, asthma, inflammatory bowel disease, and obesity (Rousounidis et al., 2011; Nathwani et al., 2019).

Increased Risk of Secondary Infections

Alteration of normal bacterial flora may also lead to an increased risk of secondary infections, including Clostridium difficile infection, which can be highly dangerous in children (Goossens et al., 2005; Sakeena et al., 2018).

RESULTS

Strategies for Reducing Pediatric Antibiotic Misuse: Solving the difficult issue of antibiotic misuse in children demands a multi-faceted strategy with interventions directed at parents, healthcare professionals, and the healthcare system as a whole. Antimicrobial stewardship programs, which also seek to maximize antibiotic use, play a pivotal role in this process. Table 2 summarizes evidence-based interventions aimed at curbing pediatric antibiotic misuse.

Table 2: Antimicrobial Stewardship Interventions and Their Potential Impact.
InterventionTarget GroupPotential Impact
Public awareness campaigns about viral vs. bacterial infection.Parents, General PublicIncreased knowledge of proper antibiotic use, decreased demand for unnecessary antibiotics.
Implementation of national prescribing guidelines with education of physicians.Healthcare ProvidersImproved practice compliance with evidence-based prescribing, lower rates of broad-spectrum antibiotic use as first-line treatment.
Availability of rapid diagnostic tests for frequent respiratory infections.Healthcare ProvidersLess diagnostic uncertainty, more targeted antibiotic use, lower use of antibiotics for viral infections.
Pharmacist counseling about antibiotic use and resistance.Patients, ParentsBetter adherence to prescribed regimens, greater understanding of antibiotic resistance and the importance of completing the full course.
Strict enforcement of prescription-only status of antibiotics.Pharmacies, PublicDecreased self-medication and over-the-counter availability of antibiotics.

Public and Parent Interventions

Public Awareness and Education Campaigns

Wide-reaching, culturally competent public health campaigns are needed to inform parents and the public regarding antibiotic resistance, the fact that antibiotics are ineffective in treating viral infections, the need to use antibiotics for the full duration prescribed, and the dangers of self-medication. Such campaigns must employ a range of communication channels, such as social media, traditional media, and community outreach programs.

Educational Materials in Healthcare Facilities

Giving parents easy-to-understand educational materials in clinics, hospitals, and pharmacies can support main messages regarding proper use of antibiotics.

Engaging Community Leaders and Opinion Leaders

Involving community leaders, schoolteachers, and other respected individuals can help spread correct information and tackle local beliefs and practices about antibiotic use.

Promoting Shared Decision-Making

Encouraging open discussion between parents and healthcare practitioners, where concerns are listened to, and treatment decisions are made together, can assist in slowing down parental pressure for inappropriate antibiotics.

Interventions Aimed at Healthcare Practitioners

Antimicrobial Prescribing Guidelines and Education

Regular updates and implementation of evidence-based national and local antibiotic prescribing guidelines for frequent pediatric infections are fundamental. Supplying healthcare professionals with continuing education and training on these guidelines, and on antimicrobial stewardship principles, is necessary to encourage optimal prescribing.

Diagnostic Stewardship

Investment in and encouragement of the use of rapid and accurate diagnostic tests can aid in distinguishing bacterial from viral infections, minimizing diagnostic uncertainty and the use of empirical antibiotic prescribing.

Peer Review and Feedback

Instituting peer review processes and offering feedback to healthcare providers on their prescribing habits can encourage identification of areas for change and adherence to guidelines.

Clinical Decision Support Systems

Incorporating clinical decision support systems into electronic health records can offer prescribers real-time guidance regarding appropriate antibiotic choice, dose, and duration.

Promoting Delayed Prescribing

In some cases, for mild infections where there is a low probability of a bacterial cause, a delayed prescribing strategy can be utilized. This entails giving parents symptomatic management advice and a prescription to fill only in case the child's condition fails to improve within a set period of time.

Involving Pharmacists in Antimicrobial Stewardship

Pharmacists have a pivotal role in dispensing antibiotics and are capable of giving useful counseling to patients and parents about their correct usage and possible side effects. Empowering pharmacists to actively engage in antimicrobial stewardship programs, such as reviewing prescriptions and educating patients, can be extremely effective.

System-Level Interventions

Strengthening Regulatory Frameworks

Enacting and enforcing strictly regulations mandating prescription-only status for all systemic antibiotics and limiting over-the-counter sales are critical.

National Action Plans on Antimicrobial Resistance

Establishing and implementing national action plans that cover all areas of antimicrobial resistance, such as surveillance, prevention, control, and research, are critical to enable a coordinated national response.

Surveillance of Antibiotic Use and Resistance

Building strong national surveillance systems to monitor patterns of antibiotic use and track the spread of antibiotic resistance among pediatric populations is vital to grasp the extent of the problem and assess the impact of interventions.

Investing in Research and Development

Sustained investment in research to produce new antibiotics, alternative treatments for bacterial infection, and rapid diagnostic tests is critical to confront the long-term challenge of antibiotic resistance.

Promoting Interprofessional Collaboration

Encouraging interprofessional collaboration among physicians, pharmacists, nurses, public health professionals, and other stakeholders is critical to enable a coordinated and effective response to fight antibiotic resistance.

Data Analysis and Findings

Although the source material gives concrete data from a population surveyed in Wardha city, in a general professional-grade article, it is more suitable to give illustrative examples of the kinds of data and findings typically seen in research on pediatric misuse of antibiotics.

CONCLUSION

Motivated by a multifaceted interplay between parental misinformation, medical habits, and institutional weaknesses, children's excessive exposure to antibiotics is a primary driver of antibiotic resistance, its future and potentially cataclysmic impact on generations to come. The emergence of untreatable infections, rising healthcare expenditure, and disruption of children's emerging microbiomes are all emergencies calling for concerted and immediate action. Stemming antibiotic abuse needs a multi-pronged and multi-faceted strategy. Focused public education efforts are essential to counter parental misconceptions and stem demand for unwarranted antibiotics. Equipping healthcare professionals with evidence-based prescribing standards, enhanced diagnostic technology, and constant education on antimicrobial stewardship will help to optimize prescribing strategies. In addition, enhancing regulatory systems to limit over-the-counter sales of antibiotics and having strong national surveillance systems in place is crucial to track antibiotic consumption and resistance patterns.

The antimicrobial stewardship principles have to be integrated into all the levels of the healthcare system, encouraging coordination among physicians, pharmacists, nurses, public health professionals, and other parties. Through joint efforts, we can encourage the appropriate use of antibiotics in children, maintain the efficacy of these lifesaving medicines, and protect the health and well-being of generations to come in the context of the growing threat of antibiotic resistance. The moment for firm and consistent action is here to prevent a possible post-antibiotic era and see to it that antibiotics continue to be an effective arsenal in our battle against bacterial infections.

REFERENCES

As published

Showing references and in-text citations exactly as published.

  1. 1.Auta, A.; Hadi, M. A.; Oga, E.; Adewuyi, E. O.; Abdu-Aguye, S. N.; Adeloye, D. et al. Global access to antibiotics without prescription in community pharmacies: A systematic review and meta-analysis. The Journal of Infection. 2019;78(3):8–18. https://doi.org/10.1016/j.jinf.2018.07.001DOIGOOGLE SCHOLAR
  2. 2.Barker, A. K.; Brown, K.; Ahsan, M.; SenGupta, S.; Safdar, N.. Social determinants of antibiotic misuse: A qualitative study of community members in Haryana, India. Global Public Health. 2017;12(11):1353–1366. https://doi.org/10.1080/17441692.2016.1178316DOIGOOGLE SCHOLAR
  3. 3.Centers for Disease Control and Prevention.. Antibiotic resistance threats in the United States. 2019.GOOGLE SCHOLAR
  4. 4.Chandy, S. J.; Naik, G. S.; Balaji, V.; Jeyaseelan, V.; Thomas, K.; Antonisamy, B. et al. High-cost burden and health consequences of antibiotic resistance: The price to pay. Journal of Infection and Public Health. 2013;6(5):370–378. https://doi.org/10.1016/j.jiph.2013.04.001DOIGOOGLE SCHOLAR
  5. 5.Charani, E.; Castro-Sánchez, E.; Sevdalis, N.; Kyratsis, Y.; Drumright, L.; Holmes, A. H.. Behavior change strategies to influence antimicrobial prescribing in acute care: A systematic review. Clinical Infectious Diseases. 2017;65(4):707. https://doi.org/10.1093/cid/cix451DOIGOOGLE SCHOLAR
  6. 6.Costelloe, C.; Metcalfe, C.; Lovering, A.; Mant, D.; Hay, A. D.. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ. 2010;340(Article c2096.). https://doi.org/10.1136/bmj.c2096DOIGOOGLE SCHOLAR
  7. 7.Davey, P.; Marwick, C. A.; Scott, C. L.; Charani, E.; McNeil, K.; Brown, E. et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. The Cochrane Database of Systematic Reviews. 2017;2(3):Article CD003543. https://doi.org/10.1002/14651858.CD003543.pub4DOIGOOGLE SCHOLAR
  8. 8.Dyar, O. J.; Huttner, B.; Schouten, J.; Pulcini, C.; ESGAP (ESCMID Study Group for Antimicrobial stewardshiP).. What is antimicrobial stewardship?. Clinical Microbiology and Infection. 2017;23(11):793–798. https://doi.org/10.1016/j.cmi.2017.08.026DOIGOOGLE SCHOLAR
  9. 9.Fleming-Dutra, K. E.; Hersh, A. L.; Shapiro, D. J.; Bartoces, M.; Enns, E. A.; File, T. M. et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016;315(17):1864–1873. https://doi.org/10.1001/jama.2016.4151DOIGOOGLE SCHOLAR
  10. 10.Friedman, N. D.; Temkin, E.; Carmeli, Y.. The negative impact of antibiotic resistance. Therapeutic Advances in Infectious Disease. 2016;3(5):217–229. https://doi.org/10.1177/2049936116667895DOIGOOGLE SCHOLAR
  11. 11.Gandra, S.; Mojica, N.; Klein, E. Y.; Ashok, A.; Nerurkar, V.; Kumari, M. et al. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008–2014. International Journal of Infectious Diseases. 2016;50:75–82. https://doi.org/10.1016/j.ijid.2016.08.002DOIGOOGLE SCHOLAR
  12. 12.Gelband, H.; Miller-Petrie, M.; Pant, S.; Gandra, S.; Levinson, J.; Barter, D. et al. The state of the world’s antibiotics 2015. Center for Disease Dynamics, Economics and Policy. 2015.GOOGLE SCHOLAR
  13. 13.Goossens, H.; Ferech, M.; Vander Stichele, R.; Elseviers, M.; M.. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. The Lancet. 2005;365(9459):579–587. https://doi.org/10.1016/S0140-6736(05DOIGOOGLE SCHOLAR
  14. 14.Gould, I. M.; Bal, A. M.. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence. 2013;4(3):185–191. https://doi.org/10.4161/viru.22507DOIGOOGLE SCHOLAR
  15. 15.Holloway, K. A.; Mathai, E.; Gray, A. L.. The problem of antimicrobial resistance in India. Indian Journal of Medical Research. 2013;138(3):105–107.GOOGLE SCHOLAR
  16. 16.Huttner, B.; Saam, M.; Moja, L.; Mah, K.; Sprenger, M.; Harbarth, S. et al. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. The Lancet Infectious Diseases. 2013;13(3):23–28. https://doi.org/10.1016/S1473-3099(12DOIGOOGLE SCHOLAR
  17. 17.Khan-Asa, B.; Punyawudho, B.; Singkham, N.; Chaivichacharn, P.; Karoopongse, E.; Montakantikul, P. et al. Over-the-counter sale of antibiotics in India: A qualitative study of providers’ perspectives across two states. Antibiotics. 2020;9(9):Article 574. https://doi.org/10.3390/antibiotics9090574DOIGOOGLE SCHOLAR
  18. 18.Laxminarayan, R.; Duse, A.; Wattal, C.; Zaidi, A. K. M.; Wertheim, H. F. L.; Sumpradit, N. et al. Antibiotic resistance—The need for global solutions. The Lancet. Infectious Diseases. 2013;13(12):1057–1098. https://doi.org/10.1016/S1473-3099(13DOIGOOGLE SCHOLAR
  19. 19.Llor, C.; Bjerrum, L.. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic Advances in Drug Safety. 2014;5(6):229–241. https://doi.org/10.1177/2042098614554919DOIGOOGLE SCHOLAR
  20. 20.McNulty, C. A. M.; Lecky, D. M.; Farrell, D.; Kostkova, P.; Adriaenssens, N.; Herotova, T. K. et al. Public awareness and antibiotic use. Journal of Antimicrobial Chemotherapy. 2013;68(11):2424–2426. https://doi.org/10.1093/jac/dkt238DOIGOOGLE SCHOLAR
  21. 21.Nathwani, D.; Varghese, D.; Stephens, J.; Ansari, W.; Martin, S.. Value-driven agenda for antibiotic stewardship in secondary care. Journal of Antimicrobial Chemotherapy. 2019;74(Suppl. 1):i2–i9. https://doi.org/10.1093/jac/dky531DOIGOOGLE SCHOLAR
  22. 22.Pharmacy Council of India.. Guidelines for Antibiotic Stewardship Programs. 2016.GOOGLE SCHOLAR
  23. 23.Rousounidis, A.; Papaevangelou, V.; Hadjipanayis, A.; Panagakou, S.; Theodoridou, M.; Syrogiannopoulos, G. A. et al. Descriptive study on parents’ knowledge, attitudes and practices on antibiotic use and misuse in children with upper respiratory tract infections in Cyprus. International Journal of Environmental Research and Public Health. 2011;8(8):3246–3262. https://doi.org/10.3390/ijerph8083246DOIGOOGLE SCHOLAR
  24. 24.Sakeena, M. H. F.; Bennett, A. A.; McLachlan, A. J.. Non-prescription sales of antimicrobial agents in community pharmacies: A systematic review. International Journal of Pharmacy Practice. 2018;26(3):5–18. https://doi.org/10.1111/ijpp.12377DOIGOOGLE SCHOLAR
  25. 25.Sulis, G.; Adam, P.; Nafade, V.; Gore, G.; Daniels, B.; Daftary, A. et al. Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis. PLOS Medicine. 2020;17(6):Article e1003139. https://doi.org/10.1371/journal.pmed.1003139DOIGOOGLE SCHOLAR
  26. 26.Van Boeckel, T. P.; Gandra, S.; Ashok, A.; Caudron, Q.; Grenfell, B. T.; Levin, S. A. et al. Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. The Lancet. Infectious Diseases. 2014;14(8):742–750. https://doi.org/10.1016/S1473-3099(14DOIGOOGLE SCHOLAR
  27. 27.Vaz, L. E.; Kleinman, K. P.; Lakoma, M. D.; Dutta-Linn, M. M.; Nahill, C.; Hellinger, J. et al. Prevalence of parental misconceptions about antibiotic use. Pediatrics. 2015;136(3):221–231. https://doi.org/10.1542/peds.2015-0883DOIGOOGLE SCHOLAR
  28. 28.Wagner, A. K.; Graves, A. J.; Reiss, S. K.; Lecates, R.; Zhang, F.; Ross-Degnan, D.. Sociobehavioral determinants of antibiotic use in a low-income country: A mixed-methods study. Clinical Infectious Diseases. 2018;67(3):473–480. https://doi.org/10.1093/cid/ciy096DOIGOOGLE SCHOLAR
  29. 29.World Health Organization.. Global action plan on antimicrobial resistance. 2015.GOOGLE SCHOLAR
  30. 30.Yadav, K.; Sahni, A.; Gautam, V.. Antibiotic stewardship in India: A situational analysis. Indian Journal of Medical Research. 2019;149(3):203–215. https://doi.org/10.4103/ijmr.IJMR_207_18DOIGOOGLE SCHOLAR

Cite this article

SELECT FORMAT

Mandal, S., & Shende, D. (2026). Antibiotic Misuse in Pediatric Populations: Causes, Consequences, and Strategies for Mitigation. International Journal of Pharmaceutical Investigation, 16(3), 984–989. https://doi.org/10.5530/ijpi.20260045